Physicians & Prescribers Psychedelic-assisted Therapy (PaT) Course
Join ATMA’s Physicians & Prescribers PaT Course, designed for busy practitioners seeking advanced knowledge in psychedelic medicine. Gain lifetime access to comprehensive learning materials, engage with industry experts, and explore a flexible learning environment to enhance your practice and self-care.
Course Info
at a Glance
Note
This course is complimentary with ATMA's Advanced PaT Certification Program
Course Dates
Ongoing, upon registration
Fees
$1,800 CAD
Number of Hours
20
Credential(s) Earned
CME Credit Eligible
Designed for professionals seeking advanced knowedge
This course provides a comprehensive exploration of psychedelic medicine across Canada, Australia, and the United States. Beyond recent research and treatment applications, it delves into varying regulatory frameworks, equipping physicians to address patient inquiries on safety, addiction, and legal boundaries concerning psychedelics. This self-paced course emphasizes assessing patient suitability and ensuring safety within evolving therapeutic protocols
Access 9 modules of pre-recorded lectures taught by esteemed instructors in the psychedelic therapy field, delivering comprehensive knowledge at your pace.
Stay updated with ongoing access to the latest clinical data and evolving regulations in the field of psychedelic therapy, ensuring informed practice in perpetuity
Connect with an online community of psychedelic practitioners and enjoy future access to a searchable directory, fostering networking opportunities and enhancing professional visibility.
What you'll learn
- Examine both contemporary and Indigenous histories surrounding psychedelics, gaining a comprehensive understanding of their cultural contexts
- Survey current research trends in psychedelic medicine, exploring ongoing studies and their implications
- Analyze the pharmacology, drug interactions, and adverse events related to psilocybin, MDMA, Ketamine, and micro-dosing, ensuring a nuanced understanding of their effects
- Develop proficiency in discussing psychedelic-assisted therapy, exploring their efficacy in treating major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, and end-of-life distress
- Master the awareness of inclusion and exclusion criteria, enabling the effective screening of patients for eligibility
- Grasp dosing principles for psychedelics, ensuring patient safety and optimizing their therapeutic experiences
- Learn the procedures to access psychedelic-assisted therapy through Canada's Special Access Program, gaining proficiency in required assessments and paperwork
- Understand the significance of a collaborative approach to psychedelic therapy, identifying qualified team members—physicians, psychotherapists, and facilitators—for patient preparation, sessions, and integration
- Explore challenges in access for marginalized populations, delve into ethical considerations within LGBTQIA+ communities, and devise strategies to address these inclusivity challenges
Simple, transparent pricing
Training for a larger team?
Want to bring your entire team on board? For group rates, please get in touch with us to learn more.
Registration Policy
- Commitment to Growth: All purchases are final, reflecting your commitment to personal exploration. We prepare each course with dedication, unable to offer refunds.
- Flexibility in Learning: If your plans change, you can transfer your spot to someone else, sharing the opportunity for discovery.
Need assistance or have questions? Contact us at training@atmajourney.com. We’re here to ensure your journey with us is seamless and enriching.
Thank you for joining us on this journey. We look forward to supporting your exploration.
View our course curriculum
Topics include: The Categories of Psychedelics, Natural vs Synthetic Compounds, Benefits of the Psychedelic Experience, Psychedelics and the Prescriber, Psychedelics in the Context of Holistic Psychiatric Care, The History of Psychedelics and Current Research and Study of Psychedelic Use.
Topics Include: General Descriptions and Uses of Psilocybin, MDMA, DMT and 5-MeO-DMT, 2C-B, 3-MMC, LSD, MEAI, and Ketamine. Pharmacology in Relation to Psychedelics, Leading Theories in Neurobiology for Psychedelics. In-depth Overview, Side Effects, Pharmacodynamics, Pharmacokinetics, and Drug Interactions for the three main psychedelics used – MDMA, Psilocybin, and Ketamine.
Topics Include: Indigenous Perspectives on Ceremonies and Medicine Circles, Bridging the Gap with Psychedelics, Access for Diverse and Under-privileged Populations and Reciprocity. Understanding the Special Access Program (SAP) Process for Prescribers to access Psilocybin and MDMA for their Patients, Psychedelics and LGTBQIA+ and BIPOC Considerations.
Topics Include: Overview of the Role of the Prescriber in Referring to a PaT Facilitator, The Value of Working with a Collaborative Team, Basic Principles of Guiding/Sitting, and Therapist Support Networks for Self-Care.
Topics Include: Codes of Ethics for Psychedelic-Assisted Therapy – Ethical Guidelines, The Importance of a Code of Ethics for PaT, How the 4 Pillars of Healthcare Ethics Should Inform PaT, The Ethical Psychedelic Practitioner. Informed Consent and the Use of Touch in PaT, Navigating Touch Options for PaT. Harm Reduction Principles.
Topics Include: The Role of Prescriber in Preparing the Patient/Client, The Role of Prescriber in Preparation and Integration.
Screening for Safety and Optimal Experiences including Screening for Red Flags and Green Flags, Assessing a Patient for PaT. Preparation Tools for Preparing a Client/Patient for PaT, Setting Intentions, and Preparation Utilizing Embodied Inquiry.
Topics Include: Dosage Consideration for Psychotropics and Psychedelics, Prescribing, Over-Prescribing, and De-Prescribing. Specific Dosage Considerations for Psilocybin and MDMA.
Topics Include: The Paradigm Shift – Comparing and Contrasting Traditional and Psychedelic-Assisted Therapy. Best Uses for Psychedelics. Addictive Potential of Psychedelics, Psychedelics for Substance Use Disorders, End of Life Distress and Palliative Care in both Clinical Trials and Therapeutic Sessions, ADHD, OCD, Depression, and Anxiety. Cautionary PaT with Personality Disorders.
Topics Include: The Role of the Prescriber for Preparation and Integration, Why Integration is Needed, The Elements of Effective Integration, Integrating the Difficult Experience, The Importance of Multiple Complementary Modalities for Integration, Trauma-Informed Psychedelic Therapy, Somatic Approach to Trauma in PaT, PaT and Wellness and the Wild 5 Wellness Program.
Ready to get started?
Begin your training with us today and take your practice to the next level, helping to shape the future of mental health care.
